XML 21 R12.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Accrued Expenses and Other Current Liabilities | 9 Months Ended
--- | ---
Sep. 30, 2022
Payables and Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 6. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following at September 30, 2022 and December 31, 2021 (dollars in thousands): Schedule of Accrued Expenses and Other Current Liabilities
|  | September 30, 2022 |  | December 31, 2021
Clinical and consulting |  | $ | 1,506 |  |  | $ | 97 |
Wages and incentives |  |  | 960 |  |  |  | 1,051 |
Legal and patents |  |  | 126 |  |  |  | 58 |
Other |  |  | 156 |  |  |  | 27 |
Total accrued expenses and other current liabilities |  | $ | 2,748 |  |  | $ | 1,233 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration